Covered recipient · General Payments record
CATHERINE H THOMPSON
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$1,133.91
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $256.45 | 15 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $131.69 | 3 |
| Lilly USA, LLC | $51.55 | 3 |
| Amgen Inc. | $49.60 | 3 |
| UCB, Inc. | $33.96 | 2 |
| ABBVIE INC. | $20.46 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.57 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.31 | 1 |
| PFIZER INC. | $17.39 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.46 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108305086 | CMS |
| Amgen Inc. | $16.81 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117700750 | CMS |
| Amgen Inc. | $13.46 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117700752 | CMS |
| Amgen Inc. | $19.33 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117700754 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.91 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101809262 | CMS |
| Janssen Biotech, Inc. | $17.21 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078431408 | CMS |
| Janssen Biotech, Inc. | $99.99 | 03/28/2024 | Education | Undisputed | 01/23/2026 | 1078431673 | CMS |
| Janssen Biotech, Inc. | $14.49 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078431377 | CMS |
| Lilly USA, LLC | $16.57 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135580042 | CMS |
| Lilly USA, LLC | $17.59 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135603299 | CMS |
| Lilly USA, LLC | $17.39 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135580044 | CMS |
| PFIZER INC. | $17.39 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131775525 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.31 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114381504 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.57 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152224761 | CMS |
| UCB, Inc. | $16.57 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143341360 | CMS |
| UCB, Inc. | $17.39 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143341365 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.